125 related articles for article (PubMed ID: 17172419)
21. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells.
Burdak-Rothkamm S; Rothkamm K; McClelland K; Al Rashid ST; Prise KM
Cancer Lett; 2015 Jan; 356(2 Pt B):454-61. PubMed ID: 25304378
[TBL] [Abstract][Full Text] [Related]
22. NBS1 directly activates ATR independently of MRE11 and TOPBP1.
Kobayashi M; Hayashi N; Takata M; Yamamoto K
Genes Cells; 2013 Mar; 18(3):238-46. PubMed ID: 23368512
[TBL] [Abstract][Full Text] [Related]
23. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
24. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.
Bogliolo M; Lyakhovich A; Callén E; Castellà M; Cappelli E; Ramírez MJ; Creus A; Marcos R; Kalb R; Neveling K; Schindler D; Surrallés J
EMBO J; 2007 Mar; 26(5):1340-51. PubMed ID: 17304220
[TBL] [Abstract][Full Text] [Related]
25. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
[TBL] [Abstract][Full Text] [Related]
26. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.
van Laar ES; Izbicka E; Weitman S; Medina-Gundrum L; Macdonald JR; Waters SJ
Int J Gynecol Cancer; 2004; 14(5):824-31. PubMed ID: 15361190
[TBL] [Abstract][Full Text] [Related]
28. ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway.
Shigechi T; Tomida J; Sato K; Kobayashi M; Eykelenboom JK; Pessina F; Zhang Y; Uchida E; Ishiai M; Lowndes NF; Yamamoto K; Kurumizaka H; Maehara Y; Takata M
Cancer Res; 2012 Mar; 72(5):1149-56. PubMed ID: 22258451
[TBL] [Abstract][Full Text] [Related]
29. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
30. The Fanconi anaemia genome stability and tumour suppressor network.
Bogliolo M; Cabré O; Callén E; Castillo V; Creus A; Marcos R; Surrallés J
Mutagenesis; 2002 Nov; 17(6):529-38. PubMed ID: 12435850
[TBL] [Abstract][Full Text] [Related]
31. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
[TBL] [Abstract][Full Text] [Related]
32. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
[TBL] [Abstract][Full Text] [Related]
33. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
Dunn J; Potter M; Rees A; Rünger TM
Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
[TBL] [Abstract][Full Text] [Related]
35. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
37. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
Nakashima S; Kobayashi S; Nagano H; Tomokuni A; Tomimaru Y; Asaoka T; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Doki Y; Mori M
Cancer Sci; 2015 May; 106(5):584-91. PubMed ID: 25736055
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-like protein UBL5 promotes the functional integrity of the Fanconi anemia pathway.
Oka Y; Bekker-Jensen S; Mailand N
EMBO J; 2015 May; 34(10):1385-98. PubMed ID: 25862789
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302.
Suresh B; Kumar AM; Jeong HS; Cho YH; Ramakrishna S; Kim KS
Biochem Biophys Res Commun; 2015 Oct; 466(2):180-5. PubMed ID: 26343459
[TBL] [Abstract][Full Text] [Related]
40. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
Yamashita T; Nakahata T
Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
